Europe — EMA

Ondansetron Novumgen

Ondondansetron, the active ingredient in Ondansetron Novumgen, is a 5-HT3 receptor antagonist presented as a unknown/unknown for unknown use.

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

Ondondansetron, the active ingredient in Ondansetron Novumgen, is a 5-HT3 receptor antagonist presented as a unknown/unknown for unknown use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron Novumgen as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

What is Ondansetron used for?

Ondansetron Novumgen g ... ... ... ... ... ... ... ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →